Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:APHA NYSE:BHC NYSE:PBH NASDAQ:TLRY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAPHAAphria$15.38$15.48$2.78▼$32.29$4.87B2.6721.83 million shsN/ABHCBausch Health Cos$6.47-0.2%$6.92$4.25▼$9.85$2.40B0.481.90 million shs1.61 million shsPBHPrestige Consumer Healthcare$61.95-1.6%$67.56$61.78▼$90.04$3.10B0.46577,097 shs472,475 shsTLRYTilray Brands$1.85+60.9%$1.05$0.35▼$1.86$1.27B2.0142.20 million shs371.30 million shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAPHAAphria0.00%0.00%0.00%0.00%0.00%BHCBausch Health Cos0.00%-3.57%-12.42%-2.84%-21.43%PBHPrestige Consumer Healthcare0.00%-0.26%-7.58%-21.16%-11.74%TLRYTilray Brands0.00%-4.96%-16.67%+177.51%-33.91%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAPHAAphria$15.38$15.48$2.78▼$32.29$4.87B2.6721.83 million shsN/ABHCBausch Health Cos$6.47-0.2%$6.92$4.25▼$9.85$2.40B0.481.90 million shs1.61 million shsPBHPrestige Consumer Healthcare$61.95-1.6%$67.56$61.78▼$90.04$3.10B0.46577,097 shs472,475 shsTLRYTilray Brands$1.85+60.9%$1.05$0.35▼$1.86$1.27B2.0142.20 million shs371.30 million shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAPHAAphria0.00%0.00%0.00%0.00%0.00%BHCBausch Health Cos0.00%-3.57%-12.42%-2.84%-21.43%PBHPrestige Consumer Healthcare0.00%-0.26%-7.58%-21.16%-11.74%TLRYTilray Brands0.00%-4.96%-16.67%+177.51%-33.91%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAPHAAphria 0.00N/AN/AN/ABHCBausch Health Cos 2.00Hold$9.0039.10% UpsidePBHPrestige Consumer Healthcare 2.50Moderate Buy$94.8053.02% UpsideTLRYTilray Brands 2.33Hold$1.944.73% UpsideCurrent Analyst Ratings BreakdownLatest TLRY, APHA, PBH, and BHC Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails9/24/2025PBHPrestige Consumer HealthcareSidotiSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeNeutral ➝ Buy$80.009/4/2025PBHPrestige Consumer HealthcareZacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold ➝ Strong Sell8/25/2025TLRYTilray BrandsJefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$1.50 ➝ $2.008/8/2025PBHPrestige Consumer HealthcareCanaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$105.00 ➝ $100.007/29/2025TLRYTilray BrandsZelman & AssociatesSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingNeutral(Data available from 9/29/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAPHAAphria$405.96M12.00$0.09 per share166.43$4.80 per share3.20BHCBausch Health Cos$9.63B0.25$7.70 per share0.84($0.89) per share-7.27PBHPrestige Consumer Healthcare$1.14B2.68$5.13 per share12.08$37.04 per share1.67TLRYTilray Brands$821.31M2.48$0.23 per share7.96$1.40 per share1.32Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAPHAAphria-$63.21M-$0.06N/A219.71N/A-36.10%-2.30%-1.66%N/ABHCBausch Health Cos-$46M$0.2624.891.39N/A0.99%-852.36%5.25%10/29/2025 (Estimated)PBHPrestige Consumer Healthcare$214.60M$4.2614.5413.021.9919.02%12.69%6.79%11/6/2025 (Estimated)TLRYTilray Brands-$2.19B-$2.31N/AN/AN/A-265.69%-6.83%-5.45%10/9/2025 (Estimated)Latest TLRY, APHA, PBH, and BHC EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails10/9/2025Q1 2026TLRYTilray Brands-$0.03N/AN/AN/A$205.75 millionN/A8/7/2025Q1 2026PBHPrestige Consumer Healthcare$1.01$0.95-$0.06$0.95$260.71 million$249.53 million7/30/2025Q2 2025BHCBausch Health Cos$0.97$0.90-$0.07$0.40$2.47 billion$2.57 billion7/28/2025Q4 2025TLRYTilray Brands-$0.03$0.02+$0.05-$1.30$250.41 million$224.54 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAPHAAphriaN/AN/AN/AN/AN/ABHCBausch Health CosN/AN/AN/AN/AN/APBHPrestige Consumer HealthcareN/AN/AN/AN/AN/ATLRYTilray BrandsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAPHAAphria0.252.361.17BHCBausch Health Cos141.901.310.98PBHPrestige Consumer Healthcare0.554.382.99TLRYTilray Brands0.202.461.49Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAPHAAphria10.30%BHCBausch Health Cos78.65%PBHPrestige Consumer Healthcare99.95%TLRYTilray Brands9.35%Insider OwnershipCompanyInsider OwnershipAPHAAphriaN/ABHCBausch Health Cos19.97%PBHPrestige Consumer Healthcare1.40%TLRYTilray Brands0.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAPHAAphria1,200316.80 millionN/AOptionableBHCBausch Health Cos20,700370.35 million296.39 millionOptionablePBHPrestige Consumer Healthcare54049.21 million48.53 millionOptionableTLRYTilray Brands2,8421.10 billion1.09 billionOptionableTLRY, APHA, PBH, and BHC HeadlinesRecent News About These CompaniesTilray Brands (NASDAQ:TLRY) Stock Price Up 60.9% - What's Next?September 29 at 7:41 PM | marketbeat.comMarkets Keep at All-Time Highs - Lots of Data Expected This WeekSeptember 29 at 7:05 PM | zacks.comPromising Penny Stocks Worth Watching - September 29thSeptember 29 at 5:17 PM | marketbeat.comSmall Cap Stocks To Watch Today - September 29thSeptember 29 at 5:17 PM | marketbeat.comTilray Stock Is Trading Higher Monday: What's Going On?September 29 at 2:51 PM | benzinga.comTilray Brands (NASDAQ:TLRY) Shares Gap Up - Here's WhySeptember 29 at 2:23 PM | marketbeat.comCannabis Stocks To Keep An Eye On - September 29thSeptember 29 at 1:01 PM | marketbeat.comCannabis stocks surge after Trump posts video touting Medicare coverage for CBDSeptember 29 at 12:41 PM | nypost.comNTilray Brands, SNDL, Innoviz Technologies, Pony AI And Other Big Stocks Moving Higher On MondaySeptember 29 at 12:11 PM | benzinga.comInvestors Purchase High Volume of Call Options on Tilray Brands (NASDAQ:TLRY)September 29 at 11:22 AM | marketbeat.comCannabis Stocks Are Roaring 20% Higher This Morning. Here's WhySeptember 29 at 7:11 AM | 247wallst.comBest Cannabis Stocks Worth Watching - September 28thSeptember 28 at 1:02 PM | marketbeat.comSell Tilray Brands Before Q1 Financials ReportSeptember 28 at 4:48 AM | seekingalpha.comCannabis Stocks To Add to Your Watchlist - September 27thSeptember 27 at 1:06 PM | marketbeat.comGoldman Sachs Group Inc. Decreases Holdings in Tilray Brands, Inc. $TLRYSeptember 27 at 4:55 AM | marketbeat.comTilray Brands (NASDAQ:TLRY) Shares Down 3.4% - Here's WhySeptember 26 at 6:57 PM | marketbeat.comCannabis Stocks Worth Watching - September 26thSeptember 26 at 1:18 PM | marketbeat.comTilray Brands (NASDAQ:TLRY) Shares Down 5.6% - Here's What HappenedSeptember 25, 2025 | marketbeat.comCannabis Stocks To Watch Now - September 25thSeptember 25, 2025 | marketbeat.comTilray Brands, Inc. to Release Q1 Financial Results on October 9, 2025September 25, 2025 | quiverquant.comQTilray Brands, Inc. to Announce First Quarter Fiscal Year 2026 Financial Results on October 9, 2025September 25, 2025 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTLRY, APHA, PBH, and BHC Company DescriptionsAphria NASDAQ:APHAAphria Inc. cultivates, processes, produces, markets, distributes, and sells medical cannabis in Canada and internationally. The company offers pharmaceutical-grade medical cannabis, adult-use cannabis, and cannabis-derived extracts and derivative cannabis products under the Solei, RIFF, Good Supply, Aphria, P'tite Pof, and Broken Coast brands. It serves patients and consumers through distributors and online. The company is headquartered in Leamington, Canada.Bausch Health Cos NYSE:BHC$6.47 -0.01 (-0.15%) Closing price 03:59 PM EasternExtended Trading$6.47 0.00 (0.00%) As of 06:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.Prestige Consumer Healthcare NYSE:PBH$61.95 -1.02 (-1.62%) Closing price 03:59 PM EasternExtended Trading$61.94 -0.01 (-0.02%) As of 06:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.Tilray Brands NASDAQ:TLRY$1.85 +0.70 (+60.87%) Closing price 04:00 PM EasternExtended Trading$1.82 -0.04 (-1.89%) As of 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas 3 Top-Rated Dividend Growth Stocks to Buy in October Top Insider Buys and Sells From September: Buy, Sell, or Hold? This ETF Weeds Out Small-Cap Underperformers Dividend ETF SCHD Draws Buyers as Fed Cuts Spark Rotation Tesla Earnings Loom: Bulls Eye $600, Bears Warn of $300 MarketBeat Week in Review – 09/22 - 09/26 Get Exposure to Millennials' Purchasing Power With This ETF Beam Global Gets Buy Rating With 101% Upside Potential Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
